Evidence map›Paper›PMID 35618311›Full record

ArticleGenes & development2022

Senescence-induced endothelial phenotypes underpin immune-mediated senescence surveillance.

Kelvin Yin, Daniel Patten, Sarah Gough, Susana de Barros Gonçalves, Adelyne Chan, Ioana Olan, Liam Cassidy, Marta Poblocka, Haoran Zhu, Aaron Lun and 7 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Redefining senescence through hepatocyte fate changes in liver diseases.Trends in endocrinology and metabolism: TEM · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. The states of senescent cells.Biochemical Society transactions · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Kelvin YinCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.ORCID 0000-0003-2993-6374
Daniel PattenInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, United Kingdom.ORCID 0000-0002-8745-0578
Sarah GoughCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Susana de Barros GonçalvesCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Adelyne ChanCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.ORCID 0000-0003-2214-0306
Ioana OlanCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.ORCID 0000-0003-0692-1831
Liam CassidyCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.ORCID 0000-0002-9312-6256
Marta PoblockaCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Haoran ZhuCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Aaron LunCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.ORCID 0000-0002-3564-4813
Martijn SchuijsCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Andrew YoungCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.ORCID 0000-0002-7522-5525
Celia Martinez-JimenezHelmholtz Pioneer Campus, Helmholtz Zentrum München, 85764 München, Germany.ORCID 0000-0002-9534-6201
Timotheus Y F HalimCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Shishir ShettyInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, United Kingdom.ORCID 0000-0002-4729-2173
Masashi NaritaCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.ORCID 0000-0001-7764-577X
Matthew HoareCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.ORCID 0000-0001-5990-9604
University of Cambridge · GBUniversity of Birmingham · GBHelmholtz Zentrum München · DETokyo Institute of Technology · JP

Funding

Cancer Research UK 19924Cancer Research UK 24453Cancer Research UK 24995Cancer Research UK 26813Cancer Research UK 29681Cancer Research UK 29959Cancer Research UK 30462Cancer Research UK C18873/A26813Cancer Research UK C52489/A19924Medical Research Council MR/R010013/1Wellcome Trust 204622/Z/16/Z
6 · The paper itself

Abstract

Senescence is a stress-responsive tumor suppressor mechanism associated with expression of the senescence-associated secretory phenotype (SASP). Through the SASP, senescent cells trigger their own immune-mediated elimination, which if evaded leads to tumorigenesis. Senescent parenchymal cells are separated from circulating immunocytes by the endothelium, which is targeted by microenvironmental signaling. Here we show that SASP induces endothelial cell NF-κB activity and that SASP-induced endothelial expression of the canonical NF-κB component

Indexed as

Cellular SenescenceNF-kappa BAnimalsEndothelial CellsEndotheliumMicePhenotypeNF-kappa Bendotheliumimmune surveillanceliverNF-κBSASPsenescence

Identifiers

PMID35618311
PMCPMC9186388
OpenAlexW4281560563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.